Background: Epicardial catheter ablation (CA) for ventricular arrhythmias (VA) is limited
Introduction
Epicardial electroanatomical mapping (EAM) followed by radiofrequency catheter ablation (RFCA) for ventricular arrhythmia (VA) is an important therapeutic option in patients after endocardial ablation failure. Despite the presence of a subepicardial substrate epicardial EAM and ablation may have important limitations. Bipolar voltage mapping might not be accurate to delineate subepicardial scar and is likely to overestimate its extent as even thin layers of epicardial fat attenuate bipolar electrogram amplitudes. [1] [2] [3] Once a potential ablation target site (TS) has been identified, delivery of RF energy needs to be withheld in the vicinity of coronary arteries, usually visualized by repeated coronary injections, or may be ineffective due to the thickness of epicardial fat which presence can only be assumed when irrigated tip ablation is ineffective. 1, 4 Cardiac multi-detector computed tomography (MDCT) can reliably visualize both coronary arteries and epicardial fat. 5, 6 Accurate real-time integration of MDCT derived coronary anatomy and fat distribution during the ablation procedure is therefore desirable.
The purpose of this study was (1) to evaluate the extent and distribution of epicardial fat in patients undergoing combined endo-epicardial mapping and ablation, (2) to assess the feasibility and accuracy of real-time integration of MDCT derived coronary anatomy and epicardial fat distribution with EAM, (3) to determine the influence of epicardial fat thickness on bipolar and unipolar voltage and ablation outcome and (4) to evaluate the potential use of the integrated MDCT to identify inappropriate ablation sites.
Methods

Patients and baseline evaluation
The study population consisted of 28 consecutive patients (21 male, 59±16 years) scheduled for combined endo-epicardial EAM and RFCA for drug refractory VA because of previous endocardial ablation failure (n=24) or a high suspicion for an epicardial substrate based on ECG criteria (n=4). [7] [8] [9] No ethics committee approval was necessary as all performed procedures were part of routine clinical protocol. Informed consent was obtained from all patients. Prior to the procedure all patients underwent transthoracic echocardiography.
When considered necessary, magnetic resonance imaging and/or nuclear imaging were performed to assess the presence of structural heart disease.
Pre-procedural MDCT acquisition and processing
Patients underwent cardiac MDCT prior to EAM. The MDCT data were analyzed using MASS software (V2009-EXP LKEB, Leiden, The Netherlands). The aortic, endocardial, pericardial and epicardial contours and proximal coronary arteries were manually traced ( Figure 1A ).
The distance between the epicardial and pericardial contours was computed to assess fat thickness. A bull's eye reconstruction of the epicardial surface was created and divided into 8 equal short-axis and 3 long-axis segments ( Figure 1B ). 5 For each segment the mean epicardial fat thickness was calculated.
Contours were converted into 3D meshes and imported into the EAM system (CARTO-XP tm , Biosense Webster Inc, Diamond Bar, CA, USA). The epicardial surface meshes were color coded according to fat thickness ( Figure 1C ). In addition, the original MDCT data were loaded into the CARTO system and cardiac structures were segmented ( Figure 1D ). All meshes and segmented images were merged to a final fusion image (FFI) using CARTOMerge (IPE) software ( Figure 1E ). 
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Electrophysiological evaluation
Electrophysiological evaluation included programmed electrical stimulation and endoepicardial EAM. The stimulation protocol consisted of 3 drive-cycle lengths (600, 500 and 400ms) with up to 3 ventricular extra stimuli at 2 RV sites and burst pacing, with and without isoproterenol (2-10µg/min). Positive endpoint for stimulation was induction of a sustained monomorphic VA lasting for >30s or requiring termination because of hemodynamic compromise. Anti-arrhythmic drugs were discontinued for at least 5 half-lives except for amiodarone (n=7).
Electroanatomical mapping and real-time image integration
Pericardial access was established through a subxiphoid puncture (n=26) or by a surgical subxiphoidal window in case of pericardial adhesions (n=2). 10 Limited EAM of the aortic root was performed with a 3.5mm, irrigated-tip catheter (NaviStar ThermoCooled, Biosense Webster Inc, Diamond Bar, CA, USA) using the CARTO system. The mapping catheter was positioned in the ostium of the left main artery (LM) confirmed by undiluted contrast injection through the mapping catheter and the position was tagged on the map. 11 Secondly, an endocardial EAM of the LV and/or RV was created. Electrograms were filtered at 30-400Hz (bipolar) and 1-240Hz (unipolar). Bipolar voltages <1.5mV were considered abnormal and bipolar voltages <0.5mV dense scar. 12 Next, the MDCT-derived images were integrated with the EAM. The images were visually aligned using the location of the LM as a landmark for registration. Subsequently, the surfaces of the LV or RV were automatically aligned using CARTOMerge software. After surface registration the position of the LM was used to assess rotation errors. 11, 13 Distances between the EAM and the FFI including the LM were calculated to evaluate registration accuracy.
Identification of ablation target sites
In idiopathic VA LV, RV, aortic sinus and/or coronary venous system activation mapping was performed. If no TS could be identified, the potential epicardial TS was predicted based on the spatial distribution of earliest local activation time. 14 The local epicardial fat thickness and vicinity of coronary arteries was assessed prior to epicardial mapping ( Figure 2A ).
For scar-related VA TS were selected based on activation and entrainment mapping for tolerated VA. For non-tolerated VA, TS were identified guided by pace-mapping (≥11/12 lead match between VA-QRS, stimulus-to-QRS interval >40ms) and/or the presence of late potentials (potentials separated by an isoelectric segment >20ms and inscribing after QRS).
Epicardial mapping and ablation
For idiopathic VA limited epicardial voltage mapping was performed, followed by detailed activation mapping of the predicted TS. In scar related VA, a regional epicardial voltage map was created of the target area. Ablation TS were defined as for the endocardium and tagged on the epicardial map.
Before epicardial ablation, the vicinity of major coronary arteries branches was estimated on the FFI and categorized into 3 categories (<5mm, 5-15mm, >15mm). Subsequently, coronary angiography (LAO45°, RAO30°) was performed and the distance between catheter tip and coronary artery was evaluated on fluoroscopy using the length of the distal electrode pair (6.7mm) and tip-proximal-electrode distance (14.9mm) as a visual reference (Figure 3 ).
The distance between the catheter tip and major coronary artery branches on the FFI and on fluoroscopy were compared to further evaluate the registration accuracy. If TS were in close proximity to a major branch additional injections were performed to confirm the accuracy of spatial relation as measured on the FFI. Ablation was usually withheld at TS with an estimated distance <5mm. High out put pacing (10mA, 2ms) was performed to determine the location of the phrenic nerve, if appropriate.
Radiofrequency energy was applied at 30-45W (maximum temperature 45ºC, flow 20-30ml/min, 60s) for endocardial sites and up to 50W (flow 20ml/min) for epicardial sites.
A successful ablation site was defined as the site where RF energy abolished the VA. In case the VA remained inducible after RF energy was applied, the ablation site was considered non-successful. The endpoint of the procedure was non-inducibility of any VA, inability to identify TS or TS locations that prevented or did not allow effective RF delivery. 
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Post-procedural evaluation of the impact of epicardial fat
After the procedure, epicardial mapping points and the registration matrix were exported from the CARTO system and superimposed on the original MDCT ( Figure 4A ). Bipolar and unipolar voltages were correlated to epicardial fat thickness using only mapping points at sites with no evidence for scar on imaging. Mapping points were grouped into three predefined categories according to epicardial fat thickness (0mm, >0≤4mm and >4mm fat). 4 To investigate the impact of epicardial fat on ablation outcome, fat thickness at successful and non-successful ablation sites was compared. In case of linear lesions, the average fat thickness was used. 
Follow-up
After discharge, patients were followed regularly at our outpatient clinic. Implantable cardioverter defibrillator interrogation was performed every 6 months. Therapy was regarded appropriate when delivered in response to any VA.
Statistical analysis
Statistical analysis was performed using SPSS, version 18.0 (SPSS, Inc., Chicago, IL, USA).
Continuous variables are expressed as mean±SD or median (interquartile range) when appropriate, and categorical variables as frequency (%). The Mann-Withney U-test or student's T-test were used to compare variables, as appropriate. All tests were two-tailed and a p-value <0.05 was considered statistically significant.
Results
Patient characteristics and pre-procedural MDCT processing
Baseline patient characteristics are summarized in Table 1 . The ventricular epicardial surface covered by fat was 65±16%; 25±15% was covered by >4mm fat. Body mass index and age showed a strong association with the percentage of the epicardial surface covered by >4mm fat (p<0.001 and p=0.008, respectively). The basal and apical anterior RV wall and the basal superior LV wall showed the thickest epicardial fat layer (5-6±3mm) ( Figure 5 ). 
Real-time image integration and registration accuracy
Endocardial voltage maps of the LV were obtained in 25 patients (structural heart disease 105±65 points, idiopathic VA 50±25 points) with an additional endocardial RV map in 9. In 3 patients only RV mapping was performed (67±23 points). Epicardial mapping was performed in all patients (structural heart disease 150±74 points, idiopathic 87±50 points).
The MDCT derived images were successfully merged to the FFI and integrated with the aortic and LV and/or RV EAM with a mean surface registration error of 2.8±1.3mm. After registration, the position error between the LM on the EAM and the FFI was 5.5±2.8mm.
Ablation target sites and procedural outcome
In 22 patients 41 VA (cycle length 382±98ms) could be induced; in 5 patients the clinical VA (idiopathic premature ventricular complexes) was present at baseline; in one patient no VA could be induced. All 46 VA were targeted (Table 2) . Seven VA (15%) in 5 patients were successfully ablated from the endocardium and 18 (39%) VA in 13 patients were successfully targeted from the epicardium (7.7±4.3 RF applications/VA).
Ablation of 21 (46%) VA in 13 patients was non-successful. Two VA in 1 LV-cardiomyopathy patient were not targeted due to proximity of the His bundle. For 5 hemodynamic non-tolerated VA in 3 patients (2 LV-cardiomyopathy, 1 arrhythmogenic right ventricular dysplasia/cardiomyopathy) no appropriate TS could be identified. In 1 patient epicardial Of interest, all ineffective ablation sites were located at the LV superior wall (2 idiopathic and 1 LV-cardiomyopathy VA) and RV anterior superior wall (1 biventricular-cardiomyopathy VA). These sites were covered by >4mm fat as delineated by the fat meshes.
MDCT-derived coronary anatomy
To further evaluate the registration accuracy, the distance between 28 TS and coronary arteries on the FFI and coronary angiography were compared. Based on the integrated FFI, in 7 patients the TS for 11 VA were located >15mm from a coronary artery, in 8 patients the TS for 8 VA were located 5-15mm and in 6 patients the TS for 9 VA were located <5mm from a coronary artery. In all cases the distance was confirmed by angiography ( Figure 3 , Table 2 ). In 4 patients (7 VA) ablation was withheld because of proximity of a coronary artery accounting for ablation failure. In 2 patients ablation was successfully performed without acute complications despite the vicinity of coronary arteries; 1 patient had a TS near a functional occluded coronary artery, the other patient who was in cardiogenic shock because of incessant VA had a TS close to the circumflex artery (distance<5mm) and RF was successfully applied. This patient died 4 weeks later due to progressive heart failure. No coronary artery lesion could be detected at autopsy ( Figure 6 ).
Procedural complications
In 1 patient a major epicardial bleeding (>80cm 3 ) occurred. Of importance, there was no damage of the LM evaluated by angiography and no procedure related death. Procedural time was 253±89 minutes and fluoroscopy time was 43±15 minutes.
Post-procedural evaluation of the impact of epicardial fat
A total of 1046 epicardial mapping points were located at the epicardium without evidence for scar on imaging. Twenty-two percent of these mapping points (n=232) were located at epicardium not covered by fat with a median bipolar voltage of 2.5mV (1.4-4.6mV) and a median unipolar voltage of 7.5mV (5.4-12.0mV). Bipolar voltages decreased significantly with increasing epicardial fat thickness according to the predefined categories (p<0.001).
However, using the previously suggested cut-off value of 2.8mm, 37% of mapping points 
Predicted epicardial target sites in idiopathic VA
In the subgroup of 7 patients without evidence of structural heart disease the earliest local activation time was similar over a broad endocardial area (Δ local activation time ≤10ms at ≥3 endocardial points >1.5cm apart) (n=2), at two remote endocardial sites (Δ local activation time ≤10ms at 2 endocardial points >1.5cm apart) (n=1) or at both an endocardial and an aortic sinus/cardiac venous site (n=4) strongly suggesting an epicardial TS. The predicted epicardial TS and its distance to the coronary arteries and the expected fat layer was confirmed after epicardial EAM and reversed registration in all patients. The area was located near (<5mm) the left anterior descending artery in 2 patients (no ablation performed) ( Figure   2B ). In 2 other patients, the TS was covered by 22.2mm and 21.0mm fat and ablation at these sites was ineffective. In 3 patients the TS was located remote (range 7.3-11.5mm) from a coronary artery and covered by 3.8±2.3mm fat. Ablation at these sites abolished the VA.
Follow-up
During a mean follow-up of 27±15 months 5 patients died (4 heart failure; 1 cancer) and 1 patient underwent heart transplantation because of terminal heart failure. Of the remaining 22 patients, 11 patients experienced VA recurrence; all 7 patients with ablation failure (100%) and 4 (27%) who were non-inducible for any VA.
Discussion
The distribution of epicardial fat and coronary arteries varies between patients. Both are of key relevance during epicardial mapping and ablation. This study is the first to demonstrate the feasibility and accuracy of real-time integration of MDCT derived images to visualize both the coronary artery anatomy and the distribution and thickness of epicardial fat before epicardial mapping. In 62% of patients with epicardial ablation failure lack of success was related to the proximity of a coronary artery or a thick epicardial fat layer both correctly identified using image integration.
Accuracy of real-time image integration
Image integration was performed using the ostium of the LM as a single landmark and by the surface registration tool provided by CARTO after limited endocardial mapping. This approach resulted in highly accurate integration of EAM and MDCT data. In all patients accuracy was verified with surface registration statistics (surface error 2.8±1.3mm) and the position error between the LM landmark on the EAM and the FFI images (5.5±2.8mm). The registration accuracy of the LM was used to assess rotation errors. The relatively large position error of this landmark is likely due to the fact that the LM is located outside the surface of the LV and RV. The absolute value of the LM position error underestimates the registration accuracy as position errors due to rotation are expected to be larger with increasing distance from the surface. For all points the mean surface registration error was only 2.8mm which is clinically acceptable keeping in mind that the used mapping catheter had a 3.5mm tip.
In contrast to all prior studies, registration accuracy was not only evaluated by the surface registration statistic. We also assessed accuracy by comparing the distance between catheter position and coronary arteries on integrated maps and coronary angiograms. Although MDCT derived epicardial fat distribution cannot directly be verified using fluoroscopy, the 3D coordinates for epicardial fat meshes and coronary anatomy were derived from the same MDCT suggesting an identical accuracy to delineate fat thickness.
Epicardial fat and voltage mapping
Up to 64% of the epicardial surface was covered with fat; a quarter with a fat layer of >4mm.
Of importance, epicardial fat was not restricted to the atrio-and interventricular groove as suggested by others. [1] [2] [3] Epicardial fat can attenuate bipolar voltages thereby preventing accurate delineation of subepicardial scar by bipolar voltage mapping. A fat layer ≥2.8mm was found to best separate low voltage (<1.5mV) from normal voltage in a prior study. 1 However, our newly proposed technique of reversed registration allowed a head-to-head comparison of voltage data and local fat thickness. Although we could confirm a decrease in bipolar voltages with increasing fat thickness, nearly 60% of all mapping points acquired in areas with fat and >37% of points acquired in areas with ≥2.8mm fat showed normal bipolar voltages. These findings underline the importance of accurate MDCT derived fat information to avoid overestimation of subepicardial scar and underestimation of epicardial fat.
In contrast to prior observations, this study demonstrates that unipolar voltages are not influenced by epicardial fat which may be caused by the larger field of view. 15, 16 Therefore, unipolar voltage mapping may be of value to indicate subepicardial or intramural scar even when a significant epicardial fat layer is present.
Epicardial fat and impact on ablation
Epicardial fat was thickest at the LV superior and RV anterior wall, which is in line with prior investigations. 5 Of interest, all ineffective RF applications were delivered in these areas.
Little is known about the effect of epicardial fat on the efficacy of RF applications. In a prior study, epicardial cooled tip ablation was unable to produce epicardial lesions applied at sites covered by a fat layer >3.5mm. 4 However, this was tested for only 3 applications in an animal model of myocardial infarction. In humans, Desjardins et al. compared epicardial fat thickness of 12 effective and 4 ineffective epicardial cooled-tip ablation sites; all ineffective ablation sites were covered by 10.8-14.6mm fat while effective ablation sites were all located at sites covered by <1.8mm fat. 1 Therefore, a cut-off value for epicardial fat thickness precluding effective epicardial ablation remained undetermined.
In the current study, ablation was performed at 21 sites covered by 0-22.2mm of epicardial fat, including 6 sites covered by 3.0-10.0mm epicardial fat. The epicardial fat thickness at ineffective ablation sites ranged from 7.3-22.2mm. In contrast, all effective ablation sites were covered by 0-6.1mm fat. These findings suggest that an epicardial fat layer <7mm allows for effective irrigated tip ablation in humans.
Predicted epicardial target sites in idiopathic VA
Real-time visualization of the coronary anatomy and fat distribution before epicardial access might be particularly important in patients with a focal arrhythmogenic source typical for idiopathic VA. Based on local activation times we could not only correctly predict the epicardial TS but also, using the pre-acquired and integrated MDCT, the proximity of coronary arteries and local fat thickness at these TS before epicardial access. Consequently, image integration may predict potential ablation failure and may thereby prevent unnecessary epicardial access in selected patients in the future.
Limitations
The comparison of successful and non-successful TS was performed retrospectively. The validation of a cut-off value of >7mm for epicardial fat preventing effective RFCA should be performed in a prospective manner in a larger group of patients.
In addition, the bull's eye reconstruction of epicardial fat reflects a simplified contour of the heart. Consequently, interpretation of the bull's eye should be performed with vigilance and is merely designed to provide a schematic overview of epicardial fat thickness and distribution.
The value of electrogram characteristics for delineation of scar was not analyzed, since the current gold standard to delineate scar (contrast-enhanced magnetic resonance imaging)
was not available during the procedure in all patients. However, the objective of this study was to demonstrate the clinical value of real-time image integration of MDCT derived data and to determine the influence of epicardial fat thickness on bipolar and unipolar electrogram voltages. Therefore, only areas without evidence for scar were evaluated.
Conclusion
Real-time image integration of pre-acquired MDCT data on coronary anatomy and fat distribution using the ostium of the LM as a single landmark with EAM is safe, accurate and feasible and available before epicardial access. One fourth of the ventricular epicardial surface is covered by >4mm fat which is predominantly present at the LV superior wall and RV anterior wall. Although bipolar voltages decrease with increasing fat thickness the exact delineation of fat based on bipolar voltage mapping is poor and may be even worse if subepicardial scar is present. In contrast, unipolar voltages are not influenced by fat thickness and might therefore be superior for identification of scar covered by epicardial fat.
Epicardial fat layers of >7mm and the presence of coronary arteries are important reasons for epicardial ablation failure. Visualization of the MDCT derived coronary anatomy and epicardial fat thickness prior to epicardial mapping is therefore of importance for the correct interpretation of local bipolar electrograms and the identification of potential harmful and ineffective ablation sites. In addition, accurate image integration after endocardial ablation failure for focal VA may even prevent unnecessary pericardial access and thereby potential complications in selected patients.
